Key result
Exogenous endothelin-1 infusion in patients with left ventricular dysfunction caused systemic vasoconstriction but not pulmonary vasoconstriction.
Why the study?
Does exogenous Endothelin-1 infusion alter pulmonary and systemic hemodynamics in patients with left ventricular systolic dysfunction?
Does exogenous Endothelin-1 infusion alter pulmonary and systemic hemodynamics in patients with left ventricular systolic dysfunction?
Exogenous ET-1 infusion in patients with left ventricular dysfunction causes systemic vasoconstriction without affecting pulmonary vascular resistance.
Answers are grounded in this paper and cite their sources.
Caution against assuming uniform ET-1 vascular effects in LV dysfunction; leaves open selective systemic targeting for future study.
Plasma levels of immunoreactive endothelin-1 (ET-1) are elevated in chronic heart failure (CHF) and have been reported to correlate closely with pulmonary hemodynamic measurements. We investigated the effects of exogenous ET-1 on the pulmonary vasculature in patients with left ventricular systolic dysfunction (LVD), with or without overt heart failure. ET-1 was infused at 1, 5, and 15 pmol/min into a distal pulmonary artery of 10 patients with LVD. Hemodynamics were measured by a thermodilution catheter and arterial line. Intravascular Doppler and local pulmonary angiography were used to assess local pulmonary blood flow in the first four patients. Systemic hemodynamic changes occurred with ET-1 infusion in a dose-dependent fashion. Mean arterial pressure (100 +/- 8-107 +/- 11 mm Hg; p < 0.01) and systemic vascular resistance (1,699 +/- 375-2,033 +/- 427 dynes/s/cm-5; p < 0.001) rose, whereas the cardiac index fell from 2.43 +/- 0.53 to 2.20 +/- 0.491/min/m2 (p < 0.002). However, mean pulmonary artery pressure (21 +/- 7 mm Hg) and pulmonary vascular resistance (151 +/- 43-147 +/- 43 dynes/s/cm-5) did not change. Exogenous ET-1, when infused into patients with LVD, causes systemic but not pulmonary vasoconstriction.
No takes yet. Share an insight, caveat, or question.
Cowburn et al. (1998) studied Left ventricular systolic dysfunction (n=10). Exogenous endothelin-1 (ET-1) vs. Baseline was evaluated on Systemic and pulmonary hemodynamics. Exogenous endothelin-1 infusion in patients with left ventricular dysfunction caused systemic vasoconstriction but not pulmonary vasoconstriction.
Synapse has enriched 10 related papers. Consider them for comparative context: